摘要:
The present invention relates to pyrazinone derivatives of formula (I): wherein R1, R2, R3, R4, R5, R6 and R7 are as herein defined; processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
摘要:
An oxygen-scavenging composition is provided that includes an oxygen-scavenging component and a catalyst. The oxygen-scavenging component, which in preferred embodiments is suitable for use in packaging articles, includes two or more oxygen-scavenging groups having different scavenging properties. In one embodiment, one of the oxygen-scavenging groups is an unsaturated bicyclic group.
摘要:
The present invention provides an oxygen-scavenging composition and articles formed therefrom. The oxygen-scavenging composition preferably includes an oxygen-scavenging polymer having an unsaturated bicyclic group, a based polymer, and an optional oxidation catalyst. The base polymer preferably includes a substituted or unsubstituted addition backbone, which may include heteratoms.
摘要:
The present invention provides a compound of formula (I) wherein W, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
摘要:
A multi-layer laminate media is provided on which information may be applied in machine or human readable form on a visible front surface by the output of one or more lasers, or other high intensity light source. In a preferred embodiment, the media has three layers including a substrate, a thermochromic layer and a light absorbent layer such as carbon black located intermediate the media substrate and the thermochromic layer. The light absorbent layer is adapted to absorb light from the light source and convert the absorbed light into heat. The heat is immediately conducted into selected portions of the thermochromic layer which is in thermal contact with the light absorbent layer, causing portions of the thermochromic layer to change visual appearance such as color to create the desired mark. The invention includes a method and apparatus for using the media in conjunction with labeling produce items.
摘要:
A system and method for remotely controlling an increased number of subsystems having an onboard locomotive control unit (LCU) and two associated operator control units (OCUs) on a single wireless channel. A time slot is assigned to each subsystem for making two-way transmissions to control the locomotive. A signal from an external timing source synchronizes each subsystem to minimize interference between transmissions from different subsystems. Time slots are assigned manually or automatically over a wireless network or by the LCU after monitoring the channel. The LCU automatically selects the direct or repeater transmission path depending upon whether or not it receives polling message responses from its associated OCUs. A GPS receiver in each subsystem receives the synchronization signal and provides geographic positioning data so the LCU can determine when to execute predefined, position-based commands. The secondary OCU may be turned off and rejoined to the subsystem without ceasing operation.
摘要:
The invention provides compounds of formula (IA), processes for their preparation, pharmaceutical compositions containing them, and their use in therapy.
摘要:
The invention provides compounds of formula (I), or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof, in which A, n, p, q, R1, R2, R3 and R4 are as defined in the specification; a process for their preparation; pharmaceutical compositions containing them; and their use in therapy.
摘要翻译:本发明提供式(I)化合物或其药学上可接受的盐或其体内可水解的酯,其中A,n,p,q,R 1,R 2, SUP> R 3和R 4如说明书中所定义; 其准备过程; 含有它们的药物组合物; 及其在治疗中的应用。
摘要:
This invention relates to a polymerizable composition for forming a photochromic article having a glass transition temperature of at least 50° C. on curing the composition comprising: (a) a polymerizable composition comprising a monomer component; and (c) a photochromic dye monomer comprising a photochromic moiety and at least one oligomer group having at least one group reactive with the monomer component during curing wherein the oligomer group comprises at least seven polyether monomer units selected from alkylenoxy and haloalkylenoxy.
摘要:
The present invention relates to an aqueous pharmaceutical formulation comprising at least one latrunculin and the formulation does not contain a substantial amount of dimethyl sulfoxide. In one embodiment, the present invention is directed to an aqueous pharmaceutical formulation comprising at least one latrunculin in an amount of 0.001-2% w/v, a non-ionic surfactant in an amount of 0.01-2% w/v, and a tonicity agent to maintain a tonicity between 200-400 mOsm/kG, at a pH between 4 to 8, wherein the latrunculin, the surfactant, and the tonicity agent are compatible in the formulation, and the formulation does not contain a substantial amount of dimethyl sulfoxide. The formulation is stable for at least six month at refrigerated temperature. The present invention further provides a method of reducing intraocular pressure, a method of treating glaucoma, a method of inhibiting wound healing after trabeculectomy, and a method of inhibiting angiogenesis.